PTX3 in the assessment of severity and outcome of acute pancratitis

PTX3 in the assessment of severity and outcome of acute pancratitis - PTX3 in the assessment of severity and outcome of acute pancratitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013583

Enrollment

Registered

2014-03-31

Start date

2014-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pancreatitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with acute pancreatitis in Saitama Medical Center, Saitama Medical University

Exclusion criteria

Exclusion criteria: except not patients with acute pancreatitis in Saitama Medical Center, Saitama Medical University

Design outcomes

Primary

Measure	Time frame
Severity and outcome of acute pancreatitis between PTX3	—

Secondary

Measure	Time frame
PTX3 versus C-reactive protein PTX3 versus procalcitonin PTX3 with operation rate and motality rate PTX3 with hospitalization PTX3 with necrotising pancreatitis	—

Countries

Japan

Contacts

Public ContactRyuichi Yamamoto

Saitama Medical Center, Saitama Medical University Gastroentelorogy and Hepatology

ryuichi5118@gmail.com049-228-3400

Outcome results